Sanofi~Synthelabo Eurostage 2005

The essential bibliography about the discussed topics will
be available at the meeting
Simultaneous translation from Spanish to Italian will be
provided
Par ticipants are kindly requested to attend the whole
Eurostage
CME CREDITS HAVE BEEN REQUESTED
U.E.M.S. (European Union of Medical Specialist)
CREDITS HAVE BEEN REQUESTED
EUROPEAN HYPERTENSION SPECIALIST OF ESH
CREDITS CERTIFIED
This Stage will take place at:
Hospital Clinico
Internal Medicine
Avda Blasco Ibañez, 17
46010 Valencia
Scientific and Organizing Secretariat
Metod & Focus Group
via Ripamonti, 129 - 20141 Milano
tel 02.525031 - fax 02.57410138 - e-mail [email protected]
Valencia
November 18th - 19th, 2005
Hospital Clínico de Valencia
CHAIR
PROF. JOSEP REDON
Servicio de Medicina Interna del Hospital Clínico de Valencia
Presidente de la Sociedad Española de Hipertensión
Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)
PROF. ACHILLE CESARE PESSINA
Direttore della Clinica Medica 4
Dipartimento di Medicina Clinica e Sperimentale
Università degli Studi di Padova
SPEAKERS
PROF. CLAUDIO FERRI
Facoltà di Medicina e Chirurgia
Dipartimento di Medicina Interna e Sanità Pubblica
Università di L’Aquila
PROF. ANDREA MEZZETTI
Facoltà di Medicina e Chirurgia
Cattedra di Medicina Interna
Università degli Studi G. d’Annunzio, Chieti
DR. JOSE M. PASCUAL
Servicio de Medicina Interna del Hospital Clínico de Valencia
PROF. ACHILLE CESARE PESSINA
Direttore della Clinica Medica 4
Dipartimento di Medicina Clinica e Sperimentale
Università degli Studi di Padova
PROF. JOSEP REDON
Servicio de Medicina Interna del Hospital Clínico de Valencia
Presidente de la Sociedad Española de Hipertensión
Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)
This Eurostage is kindly supported by:
Sanofi Aventis
November 18th, 2005
FRIDAY
09.00 – 09.30
Official opening
09.30 – 12.30
Visit to the Scientific Center
J. Redon
12.30 – 14.00
Lunch
14.00 – 14.30
The ESH-ESC guidelines 2003 for management of
hypertension: is time for changes coming?
A. C. Pessina
14.30 – 14.45
Discussion
14.45 – 15.15
Microalbuminuria: a surrogate endpoint in hypertension
J. Redon
15.15 – 15.30
Discussion
15.30 – 15.45
Coffee break
15.45 – 16.15
Cardiovascular protection in the diabetic
patient with and without nephropathy
C. Ferri
16.15 – 16.30
Discussion
16.30 – 17.30
Panel discussion
The hypertensive patient at risk: harmonizing
clinical approches by different specialists
All members of Spanish and Italian Faculty and all participants in
the Eurostage
November 19th, 2005
SATURDAY
09.15 – 09.45
Ancillary properties of sartans:
new therapeutic opportunities for hypertensive
patients with comorbid conditions
A. Mezzetti
09.45 – 10.00
Discussion
10.00 – 10.30
Hypertension in diabetes
J.M. Pascual
10.30 – 10.45
Discussion
10.45 – 11.00
Coffee break
11.00 – 13.00
Round Table
The type-2 diabetic nephropathy continuum in
hypertensive patients: state of the art and future
diagnostic, preventive and therapeutic options
All members of Spanish and Italian Faculty and all participants
in the Eurostage
13.00 – 14.30
Lunch
14.30 – 15.45
Clinical case presentation
A. Mezzetti
15.45 – 16.00
Coffee break
16.00 – 17.00
CME interactive session and questionnaire
J. Redon, A.C. Pessina
17.00 – 17.15
Closing remarks to the Eurostage